Main content
Wegovy maker, Novo Nordisk, warns of price squeeze
Shares in the Danish drugmaker behind Ozempic and Wegovy fell sharply after its boss warned price cuts will hurt before any recovery.
The maker of Ozempic says tougher competition from generics in India and China will hit profits this year. Leanna Byrne speaks to its chief financial officer.
Plus, Spain moves closer to banning social media for under-16s.
And the United States renews a trade deal giving 32 African countries duty-free access to its market.
Last on
Yesterday
15:50GMT
麻豆社 World Service
More episodes
Previous
Broadcast
- Yesterday 15:50GMT麻豆社 World Service